JESSICAH TODD: Open Payments
NPI 1689450835 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$432 in 24 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $295 · 2025 $432
Food & beverage: $432
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $68 |
| Novo Nordisk Inc | 2 | $49 |
| ABBVIE INC. | 3 | $48 |
| PFIZER INC. | 2 | $36 |
| Exact Sciences Corporation | 2 | $35 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| TOLMAR, INC. | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Corcept Therapeutics | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
Products named: CAPLYTA, Ozempic, NURTEC ODT, Cologuard Collection Kit, VRAYLAR, GVOKE HYPOPEN, JATENZO, AUSTEDO XR.
Industry payments across SC — which companies pay providers there.
